Startup profile · funding coverage
Sirona Medical funding, valuation and investors
Cloud radiology infrastructure combining image storage, reading, reporting and AI workflows.
Keep track of Sirona Medical
Save this profile to your VCT watchlist for a quick return.
Funding, valuation & investors
Answer-first snapshotLatest funding
Series D
$40 million · October 15, 2026
Latest known valuation
Not publicly disclosed
Total disclosed equity funding
$40M
Excludes debt, grants, acquisitions, secondaries, and IPO proceeds.
Current status
private
growth · San Francisco, California, United States
Investors in latest funding
Lead: Avidity Partners
Other: 8VC , GreatPoint Ventures , Rose Park Advisors , KLT
Overview
Sirona Medical develops RadOS, a cloud-native radiology platform. Its October 15, 2026 announcement disclosed $40M Series D financing, led by Avidity Partners; valuation was not disclosed.
Why Sirona Medical is interesting
A recurring clinical-software platform with substantial contracted activity. The execution questions are implementation time, conversion to live usage, retention, support costs and credible progress toward cash-flow sustainability.
Product & use cases
RadOS brings archiving, diagnostic viewing, reporting, worklists and AI workflows into one platform. The company’s more-than-12M annual imaging-exam figure refers to activity under contract, not necessarily completed live volume.
Funding history (newest first)
Series D
2026-10-15 $40 million- Avidity Partners (lead)
- 8VC (participant)
- GreatPoint Ventures (participant)
- Rose Park Advisors (participant)
- KLT (participant)
Source: https://sironamedical.com/company/press/series-d-financing
Investors in our directory
Funds linked from Sirona Medical's profile — open a fund page for stage focus and related deal articles.
Competitive landscape
The integrated platform approach contrasts with maintaining separate workflow components. Its economic advantage depends on repeatable deployment and customer outcomes, not merely adding AI features. Company claims of indefinite runway are forward-looking, not independently verified.
Industries
Market / IPO context
Editorial / static context — not a live quote.
Related funding articles
Venture Capital Tracker pieces that cover Sirona Medical's financing or category context.
Last updated:
Editorial note: AI tools assisted with research, structure, or drafting. Venture Capital Tracker retains human editorial responsibility for factual accuracy, relevance, and source quality before publication.